Disclosures for "Genetic Testing in Idiopathic Optic Neuropathy: Diagnostic Yield and Differences in Clinical Presentation"
-
Miss Nagajothi has nothing to disclose.
-
Dr. Lee has nothing to disclose.
-
Ms. Mura has nothing to disclose.
-
Ms. Steigerwald has received personal compensation for serving as an employee of Ambry Genetics. Ms. Steigerwald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vigil Neuroscience.
-
Rachel Kenney has received personal compensation for serving as an employee of Optum. Rachel Kenney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minton Education LLC.
-
Dr. Galetta has nothing to disclose.
-
An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
-
Dr. Abreu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Abreu has received research support from Adult Polyglucosan Body Disease Research Foundation. The institution of Dr. Abreu has received research support from Sanofi Genzyme. The institution of Dr. Abreu has received research support from Takeda. The institution of Dr. Abreu has received research support from Sangamo. The institution of Dr. Abreu has received research support from BDSRA Foundation.
-
Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.